Disease activity measures | r† |
---|---|
hsCRP | 0.60** |
DAS28-CRP | 0.43** |
ESR | 0.32** |
DAS28-ESR | 0.27** |
SDAI | 0.27** |
HAQ-DI | 0.24** |
Patient's Global Assessment of Arthritis Pain | 0.23** |
Physician's Global Assessment of Disease Activity | 0.23** |
American College of Rheumatology Change from Baseline (ACR-N)‡ | −0.20* |
Patient's Global Assessment of Disease Activity | 0.18* |
TJC (68 joints) | 0.17* |
CDAI | 0.16* |
SJC (66 joints) | 0.04 |
†Pearson partial correlation coefficient (r) assessed relationship between MBDA score and absolute changes from baseline at Wk 12 in the combined dose group. **p≤0.001, *p<0.05. P-value calculation based on Pearson correlation inference test. ‡ACR-N measures % improvement from baseline.